Jiansong Huang

Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

α-Actinin-1 in Megakaryocytes: Its Structure, Interacting Proteins and Implications for Thrombopoiesis.

α-Actinin-1 in Megakaryocytes: Its Structure, Interacting Proteins and Implications for Thrombopoiesis.

Journal: Biomedicines

Published: August 17, 2025

Integrin β3E726 Regulates the Switch Between Platelet Spreading and Clot Retraction by Interfering Gα13/RhoA Pathway.

Integrin β3E726 Regulates the Switch Between Platelet Spreading and Clot Retraction by Interfering Gα13/RhoA Pathway.

Journal: Thrombosis and haemostasis

Published: July 28, 2025

ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes.

ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes.

Journal: Journal of cellular and molecular medicine

Published: July 22, 2025

Blocking the m6Am methyltransferase PCIF1 releases STAT1-mediated Th1 immunity to potentiate cancer immunotherapy.

Blocking the m6Am methyltransferase PCIF1 releases STAT1-mediated Th1 immunity to potentiate cancer immunotherapy.

Journal: Nature communications

Published: July 16, 2025

α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment.

α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment.

Journal: Blood advances

Published: September 13, 2024

Tryptanthrin impairs platelet function and thrombus formation by reducing Gp1bα expression.

Tryptanthrin impairs platelet function and thrombus formation by reducing Gp1bα expression.

Journal: European journal of pharmacology

Published: August 12, 2024

Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study.

Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective study.

Journal: BMC cancer

Published: May 05, 2024

Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21).

Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21).

Journal: Hematology (Amsterdam, Netherlands)

Published: December 27, 2023

CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.

CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 20, 2023

Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.

Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.

Journal: British journal of haematology

Published: February 27, 2023

circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.

circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.

Journal: Molecular carcinogenesis

Published: January 31, 2023

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: January 21, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026